X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5657) 5657
Publication (508) 508
Book Review (201) 201
Book Chapter (22) 22
Newspaper Article (16) 16
Dissertation (6) 6
Conference Proceeding (5) 5
Book / eBook (2) 2
Magazine Article (1) 1
Newsletter (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4522) 4522
index medicus (3275) 3275
female (2441) 2441
male (2220) 2220
adult (1686) 1686
middle aged (1486) 1486
oncology (1310) 1310
treatment outcome (1310) 1310
adolescent (1043) 1043
term-follow-up (1032) 1032
rheumatology (1016) 1016
methotrexate (973) 973
child (971) 971
aged (946) 946
chemotherapy (836) 836
long-term (831) 831
cancer (813) 813
double-blind (810) 810
care and treatment (800) 800
hematology (785) 785
therapy (765) 765
risk factors (727) 727
long-term survivors (652) 652
children (644) 644
retrospective studies (644) 644
medicine & public health (632) 632
rheumatoid arthritis (596) 596
prognosis (585) 585
child, preschool (556) 556
pediatrics (532) 532
follow-up studies (526) 526
immunosuppressive agents - therapeutic use (520) 520
rheumatoid-arthritis (520) 520
gastroenterology & hepatology (500) 500
infliximab (490) 490
pharmacology & pharmacy (482) 482
immunology (478) 478
transplantation (478) 478
health aspects (465) 465
young adult (464) 464
drug therapy (459) 459
research (459) 459
analysis (452) 452
antirheumatic agents - therapeutic use (443) 443
arthritis, rheumatoid - drug therapy (424) 424
methotrexate - therapeutic use (424) 424
dermatology (423) 423
patients (392) 392
antineoplastic combined chemotherapy protocols - therapeutic use (381) 381
efficacy (374) 374
placebo-controlled trial (373) 373
disease (351) 351
animals (349) 349
severity of illness index (348) 348
psoriasis (347) 347
bone-marrow-transplantation (346) 346
quality-of-life (339) 339
antibodies, monoclonal - therapeutic use (338) 338
time factors (338) 338
acute lymphoblastic-leukemia (329) 329
arthritis (326) 326
diagnosis (326) 326
surgery (324) 324
long-term safety (317) 317
drug therapy, combination (305) 305
infant (292) 292
quality of life (290) 290
follow-up (289) 289
methotrexate - administration & dosage (289) 289
prospective studies (288) 288
medicine, general & internal (287) 287
leukemia (285) 285
methotrexate - adverse effects (284) 284
recurrence (282) 282
clinical trials (281) 281
inflammatory-bowel-disease (280) 280
abridged index medicus (277) 277
combined modality therapy (270) 270
tumor necrosis factor-alpha - antagonists & inhibitors (270) 270
crohn's disease (268) 268
mortality (265) 265
aged, 80 and over (264) 264
long-term treatment (261) 261
safety (261) 261
stem cells (257) 257
remission induction (256) 256
stem-cell transplantation (256) 256
etanercept (253) 253
survival rate (250) 250
survival (247) 247
internal medicine (246) 246
term follow-up (246) 246
long-term survival (245) 245
risk (242) 242
low-dose methotrexate (238) 238
survival analysis (237) 237
patient outcomes (235) 235
antirheumatic agents - adverse effects (233) 233
article (232) 232
crohn disease - drug therapy (232) 232
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5560) 5560
German (82) 82
French (32) 32
Spanish (11) 11
Japanese (9) 9
Polish (5) 5
Russian (5) 5
Portuguese (3) 3
Turkish (2) 2
Dutch (1) 1
Hungarian (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10093, pp. 457 - 468
Summary Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MODIFYING ANTIRHEUMATIC DRUGS | NECROSIS-FACTOR | PLACEBO | JANUS KINASE INHIBITOR | INADEQUATE RESPONSE | LONG-TERM SAFETY | PLUS METHOTREXATE | AMERICAN-COLLEGE | OPEN-LABEL | COMBINATION | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Adalimumab - adverse effects | Arthritis, Rheumatoid - drug therapy | Pyrroles - administration & dosage | Antirheumatic Agents - adverse effects | Pyrroles - adverse effects | Adult | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Antirheumatic Agents - therapeutic use | Severity of Illness Index | Piperidines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Pyrimidines - administration & dosage | Treatment Outcome | Methotrexate - adverse effects | Adalimumab - therapeutic use | Adalimumab - administration & dosage | Piperidines - therapeutic use | Pyrimidines - therapeutic use | Piperidines - adverse effects | Pyrimidines - adverse effects | Methotrexate - administration & dosage | Rheumatoid factor | Care and treatment | Analysis | Clinical trials | Arthritis | Pharmaceutical industry | Methotrexate | Rheumatology | Patients | Evidence-based medicine | Studies | Rheumatoid arthritis | Monoclonal antibodies | Rheumatism | TNF inhibitors | Janus kinase | Tumor necrosis factor-TNF | Safety | Drug therapy | Drug dosages
Journal Article
Journal Article
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 12/2019, Volume 78, Issue 12, pp. e132 - e132
Journal Article
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 11/2002, Volume 137, Issue 9, pp. 726 - 733
Journal Article